Wu San-Gang, Sun Jia-Yuan, Yang Li-Chao, Zhou Juan, Li Feng-Yan, Li Qun, Lin Huan-Xin, Lin Qin, He Zhen-Yu
Xiamen Cancer Center, Department of Radiation Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, People's Republic of China.
Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Department of Radiation Oncology, Collaborative Innovation Center of Cancer Medicine, Guangzhou, People's Republic of China.
Oncotarget. 2015 Nov 3;6(34):36911-22. doi: 10.18632/oncotarget.5366.
To compare the log odds of positive lymph nodes (LODDS) with the number of positive lymph nodes (pN), lymph node ratio (LNR), removed lymph node (RLN) count, and negative lymph node (NLN) count in determining the prognosis of patients with esophageal squamous cell carcinoma (ESCC) after esophagectomy. The records of patients with ESCC who received esophagectomy were retrospectively reviewed. The log-rank test was used to compare curves for overall survival (OS), and Cox regression analysis was performed to identify prognostic factors. The prognostic performance of the different lymph node staging systems were compared using the linear trend chi-square test, likelihood ratio chi-square test, and Akaike information criterion. A total of 589 patients were enrolled. Univariate Cox analysis showed that pN stage, LNR, RLN count, NLN count, and the LODDS were significantly associated with OS (p < 0.05 for all). Multivariate Cox analysis adjusted for significant factors indicated that LODDS was independent risk factor on overall survival (OS), and a higher LODDS was associated with worse OS (hazard ratio = 3.297, 95% confidence interval: 2.684-4.050, p < 0.001). The modified Tumor-LODDS-Metastasis staging system had better discriminatory ability, monotonicity, and homogeneity, and better optimistic prognostic stratification than the Tumor-Node-Metastasis staging system in determining the prognosis of patients with ESCC. The LODDS staging system was superior to other lymph node classifications in determining the prognosis of patients with ESCC after esophagectomy. LODDS may be incorporated into esophageal staging system if these results are eventually confirmed by other studies.
比较阳性淋巴结对数优势比(LODDS)与阳性淋巴结数量(pN)、淋巴结比率(LNR)、切除淋巴结(RLN)计数和阴性淋巴结(NLN)计数在确定食管鳞状细胞癌(ESCC)患者食管切除术后预后中的作用。对接受食管切除术的ESCC患者的记录进行回顾性分析。采用对数秩检验比较总生存期(OS)曲线,并进行Cox回归分析以确定预后因素。使用线性趋势卡方检验、似然比卡方检验和赤池信息准则比较不同淋巴结分期系统的预后性能。共纳入589例患者。单因素Cox分析显示,pN分期、LNR、RLN计数、NLN计数和LODDS与OS显著相关(均p<0.05)。对显著因素进行校正的多因素Cox分析表明,LODDS是总生存期(OS)的独立危险因素,较高的LODDS与较差的OS相关(风险比=3.297,95%置信区间:2.684-4.050,p<0.001)。在确定ESCC患者的预后方面,改良的肿瘤-LODDS-转移分期系统比肿瘤-淋巴结-转移分期系统具有更好的辨别能力、单调性和同质性,以及更好的乐观预后分层。在确定食管切除术后ESCC患者的预后方面,LODDS分期系统优于其他淋巴结分类。如果这些结果最终得到其他研究的证实,LODDS可纳入食管分期系统。